#JAMALive Q&A: Paul Offit, MD; COVID19 Vaccine Update
Join us Monday for Paul Offit on the COVID19 vaccines coming through phase 2 and 3 trials. Let us know if you’ll join at http://ja.ma/addevent824 • Earn Free…
Join us Monday for Paul Offit on the COVID19 vaccines coming through phase 2 and 3 trials. Let us know if you’ll join at http://ja.ma/addevent824 • Earn Free…
This cohort study evaluates the association of a virtual synchronized prehabilitation program with perioperative outcomes among patients undergoing thoracic cancer surgery.
This secondary analysis of a randomized clinical trial investigates the effect of spironolactone and cyproterone acetate hormone therapy on the QT interval corrected for heart…
This cohort study assesses the association of germline cancer-predisposition variants with outcomes among children with rhabdomyosarcoma.
This cross-sectional survey study evaluates oncologists’ views on the ethical domains of the use of artificial intelligence (AI) in clinical care, including familiarity, predictions, explainability,…
This cohort study examines the association of reduced alcohol consumption with risk of major cardiovascular events among individuals who drink heavily.
This cohort study examines whether emergency department visits and hospital stays within 12 months of trial enrollment are more common among Medicare enrollees who live…
This cohort study of patients with gastric cancer in China examines the survival benefit associated with anti–Helicobacter pylori treatment after radical gastrectomy.
This cohort study describes and compares clinical and radiographic features, treatment responses, and outcomes of neuroinvasive West Nile virus infection in individuals with and without…
This economic evaluation examines the health expenditures related to medicines used for treatment of diabetes worldwide.
This secondary analysis of the ECOG-ACRIN E1A11 trial analyzes the association of patient-reported adverse effects with early treatment discontinuation in patients with multiple myeloma.